According to Nectar Lifesciences 's latest financial reports the company's current revenue (TTM ) is โน17.33 Billion. In 2023 the company made a revenue of โน16.32 Billion an increase over the revenue in the year 2022 that were of โน16.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โน16.78 B | 2.86% |
2023 | โน16.32 B | 1.25% |
2022 | โน16.12 B | 4.53% |
2021 | โน15.42 B | -12.31% |
2020 | โน17.58 B | -32.29% |
2019 | โน25.97 B |